Cargando…

Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer

BACKGROUND: The ability to accurately predict which patients will achieve a pathologic complete response (pCR) after neoadjuvant chemotherapy could help identify those who could safely be spared the potential morbidity of axillary lymph node dissection. We performed a retrospective analysis of a coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladak, Farah, Chua, Natalie, Lesniak, David, Ghosh, Sunita, Wiebe, Ericka, Yakimetz, Walter, Rajaee, Nikoo, Olson, David, Peiris, Lashan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834246/ https://www.ncbi.nlm.nih.gov/pubmed/35135785 http://dx.doi.org/10.1503/cjs.012920

Ejemplares similares

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Yu, Chi-Chang, et al.
Publicado: (2022)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis
por: Kim, Ji Young, et al.
Publicado: (2015)

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
por: Choi, Hee Jun, et al.
Publicado: (2018)

Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
por: Wang, Wenyan, et al.
Publicado: (2022)

Prediction of axillary response after neoadjuvant chemotherapy in clinical node positive breast cancer
por: Zheng, Weizhen, et al.
Publicado: (2021)

Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
por: Wang, Mengshen, et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

Augmented Reality Guided Needle Biopsy of Soft Tissue: A Pilot Study
por: Asgar-Deen, David, et al.
Publicado: (2020)

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection
por: Erbes, Thalia, et al.
Publicado: (2014)

Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy
por: Cao, Xiao-Shan, et al.
Publicado: (2016)

Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients
por: Li, Zhuoxuan, et al.
Publicado: (2022)

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
por: van Zeeland, Marianne, et al.
Publicado: (2020)

Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
por: Maeshima, Yurina, et al.
Publicado: (2021)

Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
por: Zhang, Hao, et al.
Publicado: (2023)

Improved Model for Predicting Axillary Response to Neoadjuvant Chemotherapy in Patients with Clinically Node-Positive Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer
por: Al-Hattali, Samia, et al.
Publicado: (2019)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021)

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration
por: Yu, Yue, et al.
Publicado: (2016)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
por: Garcia-Tejedor, Amparo, et al.
Publicado: (2023)

Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
por: Stafford, Arielle, et al.
Publicado: (2020)

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Murthy, Vijayashree, et al.
Publicado: (2021)

Marking Techniques for Targeted Axillary Dissection Among Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Gante, Inês, et al.
Publicado: (2023)

Radiographic identification of a positive clipped axillary lymph node in a mastectomy specimen following neoadjuvant chemotherapy
por: Seto, Andrew, et al.
Publicado: (2023)

Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Park, Seho, et al.
Publicado: (2018)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
por: Ling, Diane C., et al.
Publicado: (2019)

Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer
por: Simons, J. M., et al.
Publicado: (2019)

Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021)

Axillary surgery in the case of limited involved axillary lymph nodes
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
por: Straver, Marieke E., et al.
Publicado: (2010)

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
por: Choi, Hee Jun, et al.
Publicado: (2019)

Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy
por: Takatsuka, Daiki, et al.
Publicado: (2023)

Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011)

Micrometastases in axillary nodes: Out of the reckoning?
por: Singh, Akshita, et al.
Publicado: (2016)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Axillary Reverse Mapping in Patients Undergoing Axillary Lymph Node Dissection: A Single Institution Experience From India
por: Jena, Sanghamitra, et al.
Publicado: (2021)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis
por: Wang, Li, et al.
Publicado: (2020)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_652oufhn9pfmip7o30tif86qog